Logo
For Sales: 888.816.4721 | Contact Us


News & Events

Subscribe to our mailing list


Upcoming Webinar to Discuss Functional Brain Imaging Using MRI
WorldCare Clinical (WCC), a leading provider of imaging services for clinical trials, today announced a free webinar on Functional Brain Imaging Using MRI (FMRI).
October 28, 2016 - read more
WorldCare Clinical Appoints Andrea Falkoff Vice President, Operations
WorldCare Clinical (WCC), a leading provider of imaging services for clinical trials, today announced that Andrea Falkoff has been appointed Vice President of Operations.
September 12, 2016 - read more
Upcoming Webinar to Discuss the Assessment of Tumor Burden and Clinical Benefit in Clinical Trials
On Monday, September 19, 2016, Xtalks will host a complimentary webinar discussing the assessment of tumor burden and clinical benefit in immunotherapy clinical trials.
August 28, 2016 - read more
2016 BIO International Convention
WCC will be attending the show and featuring its imaging core lab and endpoint adjudication services
June 06, 2016 - read more
WorldCare Clinical President to Present at CBI Endpoint Adjudication Conference
WorldCare will discuss adjudication malignancy events in non-oncology trials
May 01, 2016 - read more
WorldCare Clinical and Mint Medical Announce Joint Oncology Offering
Leading Imaging CRO Adds State-of-the-Art Analysis Software to Oncology Offering
March 16, 2016 - read more
Outsourcing in Clinical Trials
San Mateo Event Center, San Mateo, CA
February 10-11, 2016

February 10, 2016 - read more
Partnerships in Clinical Trials
CCH Congress Center, Hamburg, Germany
November 17-19, 2015

November 17, 2015 - read more - source
WorldCare Clinical Extends European Trial Capability
Leading Imaging CRO Opens New Operations Facility in Basel
November 06, 2015 - read more
Upcoming Webinar to Provide An Overview and Guide to Clinical Trial Endpoint Adjudication
Featured speakers include Dr. Richard Walovitch, President of WorldCare Clinical, and Dr. Glenn Bubley, Director of Genitourinary Medical Oncology at Beth Israel Deaconess Medical Center.
October 27, 2015 - read more - source
WorldCare Clinical Expands Imaging Operations in Europe
Imaging Veteran Dr. Klaus Noever Strengthens WorldCare’s Oncology Imaging Expertise
October 12, 2015 - read more
Outsourcing in Clinical Trials New England
Sheraton Boston, Boston, MA
September 16-17, 2015

September 16, 2015 - read more
WorldCare Clinical Expands Its Oncology Clinical Trial Services to Include Independent Assessments of Drug-Induced Cancers
Integrated "On Demand" Pathology and Oncology Diagnostic Services Will Type Any Malignancies
June 25, 2015 - read more
WorldCare Clinical President to Present at CBI Endpoint Adjudication Conference
WorldCare will discuss how its Blinded Independent Central Review (BICR) process brings consistency to endpoint adjudication for clinical trials
May 01, 2015 - read more
WorldCare Clinical Continues to Expand Operations to Support Global Trial Imaging
Leading Imaging Company Opens New Operations Facility in San Francisco Bay Area
April 02, 2015 - read more
WorldCare Clinical to Lead Development of fMRI Brain Mapping Program
Functional MRI paradigm to aid CNS drug development
March 16, 2015 - read more
WorldCare Clinical achieves 150 Percent Increase in Sales in 2014
Diverse customer base entrusts WorldCare Clinical with studies across therapeutic areas
January 15, 2015 - read more
WorldCare Clinical Appoints Aaron Timm as CEO
Imaging Veteran to Lead WorldCare’s Global Expansion
November 18, 2014 - read more
WorldCare Clinical Publishes Research Manuscript Demonstrating How a Central Image Review Can Reduce Overall Clinical Trial Costs
Decreasing image interpretation variability in cancer trials can result in decreased trial sample size, thus driving a decrease in trial cost
November 12, 2013 - read more
WorldCare Clinical Collaborates with Leading Researcher to Publish an Endpoint Assessment Committee Review Article
BOSTON, MA, October 29, 2013 – WorldCare Clinical (WCC), a leading CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced a new peer-reviewed article entitled, “Subjective .....
October 29, 2013 - read more
ProScan Imaging Group Acquires 100 Percent Ownership of WorldCare Clinical LLC
Acquisition provides growth opportunities and increases synergies within the ProScan Family of Companies
October 15, 2013 - read more
WorldCare Clinical Appoints Melissa Gebhardt to Lead Business Development and Marketing Strategy
WorldCare Clinical, LLC (WCC), a leading imaging CRO focused on maximizing the precision and accuracy of independent assessments in clinical trials, today announced that Melissa Gebhardt has been appointed vice president of business development and marketing.
October 09, 2013 - read more
WorldCare Clinical Introduces New Service for Oncology Imaging Studies Involving Immune-Related Response Criteria (irRC)
New Service Enables Combination Tumor Assessments using both RECIST and irRC
August 08, 2013 - read more
WorldCare Clinical Exhibits at 22nd Partnerships in Clinical Trials and Joins Massachusetts General Hospital (MGH) Department of Radiology and Harvard Medical School Department of Continuing Education at “Imaging Biomarkers in Clinical Trials”
WorldCare Clinical Exhibits at 22nd Partnerships in Clinical Trials and Joins Massachusetts General Hospital (MGH) Department of Radiology and Harvard Medical School Department of Continuing Education at “Imaging Biomarkers in Clinical Trials”
April 23, 2013 - read more
WorldCare Clinical Publishes Guidance on Defining the Process For Independent Endpoint Review Services in Clinical Trials
WCC President Rick Walovitch to Present on Central Review for Trials with Subjective Endpoints at CBI Bio/Pharmaceutical Imaging Forum on December 11th
December 10, 2012 - read more
WorldCare Clinical Expands Globally with New Offices across Europe, S America and Asia Pacific
Leverages established clinical infrastructure to facilitate real-time global site support
November 13, 2012 - read more
Outsourcing-Pharma.com – WorldCare Clinical has launched a blinded independent safety and efficacy review service to speed FDA approval of clinical trial data.
WorldCare Clinical launches clinical trials review service at request of FDA
October 02, 2012 - source
WorldCare Clinical Introduces New Independent Review Services by Subspecialty-Trained Clinicians for Trials with Subjective Endpoints
Endpoint Assessment Committee Services Bring Precision and Accuracy to Blinded Independent Central Review
October 01, 2012 - read more
TODAY ON PHARMALIVE.COM – WorldCare Clinical Unveils New Services for Trials with Subjective Endpoints
Associate Web Editor Mia Burns interviewed WCC President Dr. Richard Walovitch about the launch of WCC’s new Endpoint Assessment Committee services. The EAC services are for blinded independent central review of clinical trial data, and as Dr. Walovitch explains, from a regulatory standpoint, the FDA needs to know that bias is not being introduced into clinical trial data.
June 01, 2012 - source
Contract Pharma - WorldCare Clinical Names Kenneth O’Brien Executive Director of Quality & Regulatory Affairs.
April 18, 2012 - source
WorldCare Clinical Appoints New Executive Director of Quality and Regulatory Affairs
Seasoned Veteran Brings Extensive Quality, Computer Systems and Regulatory Background to Imaging CRO
April 17, 2012 - read more
PharmaVoice - Imaging in Clinical Trials – Removing Bias and Increasing Precision and Accuracy.
April 01, 2012 - source
PharmaVoice - What's New
In response to FDA guidance and growing requests from other regulatory agencies that place new emphasis on assessing and minimizing cardiovascular risk, WorldCare Clinical has added a service offering that supports expert readers in a timely and transparent manner to complete cardiovascular endpoint committee reviews quickly and cost-effectively.
April 01, 2012 - source
WorldCare Clinical Introduces New 24-Hour Turnaround Services for Imaging Safety Reviews
Service leverages practicing, board-certified, sub specialty-trained radiologists for increased patient safety
March 13, 2012 - read more
Health Imaging Hub - WorldCare Clinical Organizes Conference on Imaging in Trials
WorldCare Clinical, LLC (WCC), a leading medical imaging CRO concentrating on making medical imaging in trials more precise, announced recently that it will organize a conference on “Imaging in Clinical Trials – Removing Bias and Increasing Precision and Accuracy”.
March 01, 2012 - source
WorldCare Clinical, in Conjunction With the Massachusetts General Hospital (MGH) Department of Radiology, Announces the Imaging Biomarkers in Clinical Trials Conference
Bree Bolognese
February 27, 2012 - read more
Applied Clinical Trials - WorldCare Clinical Establishes CV Endpoint Committees
WorldCare Clinical Expands Capabilities with Introduction of New Service Offering for Cardiovascular Endpoint Committees.
February 14, 2012 - source
WorldCare Clinical Expands Capabilities with Introduction of New Service Offering for Cardiovascular Endpoint Committees
Bree Bolognese
February 13, 2012 - read more
Applied Clinical Trials - Enrollment: More Than Numbers
WCC President Richard Walovitch, PhD, Associate Director of Biostatistics and Data Management Vincent J. Girardi III and Director of Regulatory Affairs John Tomera, PhD, discuss how partnering with CROs and using a blinded independent central review can increase trial success.
February 01, 2012 - source
International Clinical Trials - Picture of Perfection
WCC Executive Vice President, Business Development Richard Taranto and President Richard Walovitch, PhD provide an insight into imaging CROs in central and eastern Europe, including guidelines and best practices for standardization of imaging equipment for clinical trials.
October 01, 2011 - source
WorldCare Clinical's WorldPRO Suite Evolves to Support Complex Endpoint Assessment Committee (EAC) Reviews
Advanced clinical trial image management system supports integrated radiology, dermatology, pathology, and clinical data to maximize EAC effectiveness
September 20, 2011 - read more
R&D Directions - Faster Alzheimer’s Detection in Sight
WCC President Dr. Richard Walovitch, along with thought leaders from Drexel University, Merck & Co. and Icon Medical Imaging, share their thoughts on how the approval of imaging agents can enable earlier diagnosis of Alzheimer’s disease and potentially pave way to better therapies in a feature on “Solutions for Clinical Trial Imaging – Central Nervous System” in the September 2011 issue of R&D Directions (pg 42-43). In his discussion, Walovitch specifically shares his viewpoints on the value that imaging biomarkers can play in detecting the risk of Alzheimer’s and other forms of dementia at the preclincial stage, when drug therapies have the potential to be most effective. (Subscription required)
September 02, 2011 - source
Applied Clinical Trials - Improving Outcomes in Late-Stage Trials with Independent Reviews
WCC Executive Vice President, Business Development Richard Taranto and President Richard Walovitch, PhD, discuss how outcomes in late-stage trials can be improved with a blinded independent central review (BICR).
September 01, 2011 - source
WorldCare Clinical Sponsors Evolution Summit 2011 for Leading Drug Development Executives
Marcus Evans Summits’ exclusive event to feature thought leaders from across the pharmaceutical and biotechnology industries
April 25, 2011 - read more
Applied Clinical Trials - Imaging CROs in Asia
WCC Executive Vice President, Business Development Richard Taranto and President Richard Walovitch, PhD, discuss considerations for oncology trials in Asia, including the value of reader variability training and testing.
April 01, 2011 - source
Applied Clinical Trials - Applied Clinical Trials’ Business and News Update
WorldCare Clinical (Boston, MA) has promoted Richard Walovitch, PhD, from Chief Medical Officer to President, and Xiaozhou Ma, MD, has joined as Associate Director of Quantification and 3D Imaging.
February 01, 2011 - source
RT Image - DICOM Izer Eases Digital Film Conversion
WCC Director of Software Engineering Patrick Chokron talks about digitizing films in RT Image using ETIAM’s DICOM Izer. The device, which scans, formats and archives images to prepare them for interpretation, allows images to remain completely anonymous by masking any patient identification before sending them to WCC’s PACS for use by reading radiologists.
December 13, 2010 - source
WorldCare Clinical Appoints New Associate Director of Quantification and 3D Imaging
WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Xiaozhou Ma has joined the organization as associate director of quantification and 3D .....
December 06, 2010 - read more
WorldCare Clinical Promotes Richard Walovitch, PhD, to President
WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology and medical device industries, today announced that it has promoted Richard Walovitch, Ph.D., formerly chief medical officer, to president......
November 10, 2010 - read more
International Clinical Trials - Clinical Trials of the Future
WCC Director of Regulatory Affairs Dr. John F Tomera explains the impact that portfolio management, adaptive design, scheduled interim analysis, and clinical imaging CROs can have on clinical trials in the May 2010 issue of International Clinical Trials (pg. 48-52).
May 05, 2010 - source
Applied Clinical Trials - A Team Approach
WCC Chief Medical Officer Dr. Richard Walovitch and Director of Regulatory Affairs Dr. John F. Tomera explore how independent endpoint assessment committees can overcome imaging limitations in oncology trials in the May 2010 issue of Applied Clinical Trials (pg 18-22). Featured in the “Oncology & Clinical Trials in the 21st Century” supplement, Drs. Walovitch and Tomera discuss the importance of blinding patient data and implementing a streamlined technical approach to effectively demonstrate efficacy via tumor assessment endpoints.
May 01, 2010 - source
FOCUS - Adjudication in Oncology Trials: A Concept Whose Time Has Come
WCC Chief Medical Officer Dr. Richard Walovitch joins Director of Biostatistics and Data Management Asli Memisoglu and Associate Director of Clinical Operations Denise Walsh for an overview of clinical imaging endpoints and the regulatory requirements surrounding them in the inaugural issue of PharmaNet Development Group’s FOCUS newsletter. The group makes the case for the use of adjudication in oncology trials specifically, highlighting the importance of independent endpoint assessment committees and the necessary considerations for readying data for the FDA.
December 03, 2009 - source
Radiology Business Journal - Contract Research Organizations: Radiology’s Newest Revenue Stream
WCC Chief Medical Officer Dr. Richard Walovitch and Vice President of Business Development Rick Taranto examine the growth of the imaging CRO and what it means for radiology in the August/September 2009 issue of Radiology Business Journal. In a discussion of the trends toward imaging in clinical trials, Dr. Walovitch and Taranto elaborate on WCC’s approach to improving reader reproducibility and the growing importance of volumetric analysis with advanced modalities.
September 10, 2009 - source
International Clinical Trials - Metrics and Trial Management
WCC Chief Medical Officer Dr. Richard Walovitch and Director of Biostatistics and Data Management Asli Memisoglu explore the ins and outs of imaging study start-up, including the implementation of standardized performance metrics, in the August 2009 issue of International Clinical Trials (pg 46-50). In their explanation of the benefits of working with an imaging CRO, Dr. Walovitch and Memisoglu emphasize the importance of metrics to overall trial management and success.
August 01, 2009 - source
WCC Implements MCC's Imaging Performance Metrics in Support of Standardized Performance for Trials
Using its WorldPro™ technology platform, WCC implements metrics to help foster improved performance, efficiency and effectiveness for sponsors conducting imaging trials
June 22, 2009 - read more
Contract Pharma - Clinical Trial Imaging: Innovations, Trends and Challenges
WCC Chief Medical Officer Dr. Richard Walovitch and Vice President of Business Development Rick Taranto join the director of imaging at Charles River Laboratories to address the latest innovations, industry trends, and challenges in clinical trial imaging from the CRO/provider perspective in the June 2009 issue of Contract Pharma.
June 01, 2009 - source
ClinPage - 3 WorldCare Hires
“WorldCare Clinical is on a hiring binge. The imaging-focused contract research organization (CRO), which was spun off from Massachusetts General Hospital 17 years ago, has hired three top-level executives in the last five months.”
May 03, 2009 - source
R&D Directions - Image Boost
WCC Chief Medical Officer Dr. Richard Walovitch discusses the value of imaging to earlier and more effective go/no-go decisions in the drug development process in a feature on “Solutions for Clinical Trial Imaging” in the May 2009 edition of R&D Directions (pg 32-34). In a discussion of the advances of molecular imaging and its impact on R&D, Dr. Walovitch joins fellow scientists from around the clinical trial imaging world. (Subscription required)
May 02, 2009 - source
WCC Grows Executive Team with Appointment of New Associate Director of Imaging Services
WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology and medical device industries, today announced that Robert Fetterman has joined the organization as associate director of imaging services. In .....
April 13, 2009 - read more
Specialty Pharma - CRO Trends & Drivers: Specialty Pharma & Biotech Driving Current CRO Growth and Trends
WCC Chief Medical Officer Dr. Richard Walovitch joins executives from Charles River, Quanticate, and Biopharmaceutical Research Inc. for an industry roundtable in Specialty Pharma‘s feature inside Drug Delivery Technology‘s April 2009 issue (pg 64-68). Addressing several CRO industry trends identified by Frost & Sullivan, Dr. Walovitch discusses the movement toward growing sponsor engagement and integration with CROs, particularly in IT system decision-making and management, and earlier-stage studies.
April 01, 2009 - source
Mass High Tech - Walovitch Pictures Growth Potential at WorldCare
“As an author and a scientist, Richard Walovitch has been trying to find ways to give back to the industry he has been involved in for more than 20 years. He has now taken that expertise in preclinical and clinical development into the position of chief medical officer at WorldCare Clinical LLC.”
March 13, 2009 - source
ClinPage - WorldCare Enhances System
“Imaging for clinical trials is a hot area, and getting hotter. WorldCare Clinical is beefing up its image management system and tapping its access to top radiologists in the U.S. and less expensive locales.”
March 10, 2009 - source
FierceBiotech - WorldCare Launches Imaging Tech Service
Imaging CRO WorldCare Clinical has launched a service that allows imaging data to be collected, standardized according to the imaging protocol, and held in a database until a central review is requested. The service – called Collect, Ready, Hold – uses the Boston-based company’s WorldPro image management tech to acquire and prepare imaging data.
March 03, 2009 - source
WorldCare Clinical Introduces New Collect, Ready, Hold Service for Early-Stage and Phase II Trials
WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology, and medical device industries, today introduced a new service offering to support sponsors conducting early-stage and Phase II clinical trial.....
March 02, 2009 - read more
WorldCare Clinical to Exhibit at CBI's 6th Annual Medical Imaging for Clinical Trials
WHO: WorldCare Clinical (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology, and medical device industries, will exhibit at the Center for Business Intelligence’s (CBI) 6th Annual Medical Imaging for Clinical Tri.....
February 26, 2009 - read more
WorldCare Clinical to Exhibit at IIR's 7th Annual Partnering with Central Labs, ECG and Imaging Labs
WHO: WorldCare Clinical (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology, and medical device industries, will exhibit in booth 408 at the Institute for International Research’s (IIR) 7th Annual Partnering with.....
January 26, 2009 - read more
WorldCare Clinical Appoints Industry Veteran Richard Walovitch as Chief Medical Officer
WorldCare Clinical,LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology, and medical device industries, today announced that Richard Walovitch, Ph.D., has joined the organization as chief medical officer. Dr. Walovit.....
January 12, 2009 - read more
WCC Strengthens Executive Management Team with New Regulatory Affairs and Associate Medical Director
WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology, and medical device industries, today announced that John Tomera, Ph.D., has joined the organization as director of regulatory affairs and asso.....
November 17, 2008 - read more
R&D Directions - CROs in Front: Long-Term Investment
WCC President Rick Taranto lends his outsourcing industry experience to the annual CRO industry report in the September 2008 issue of R&D Directions (pg 20-27). As the contributing expert on the role of specialty imaging CROs to the drug development process, Mr. Taranto highlights the growing trend among sponsors toward earlier engagement with imaging partners. (Subscription required)
September 01, 2008 - source
Contract Pharma - Clinical Use of Imaging Biomarkers: How to Improve the Efficiency of Clinical Development
ProScan CEO and WCC Chief Medical Officer Dr. Stephen Pomeranz discusses validating biomarkers as surrogate endpoints in clinical trials in Contract Pharma‘s annual June DIA issue (pg 100-103). In his look at the progress of biomarker utilization and regulatory acceptance since the FDA’s Critical Path launch, Dr. Pomeranz calls out the requirements for using imaging in clinical trials and highlights its value with a sample study using cardiac multi-slice CT to test the effectiveness of a potential treatment for cardiovascular disease.
June 01, 2008 - source
Applied Clinical Trials - Latest Imaging Technology a Good Fit for New Therapies
ProScan CEO and WCC Chief Medical Officer Dr. Stephen Pomeranz and ProScan research assistant Dr. Resham Mendi introduce the Dynamic contrast-enhanced MRI procedure and discuss its acquisition during clinical trials in the May 2008 issue of Applied Clinical Trials (pg 10-12). As part of a supplement on “Oncology and Clinical Trials in the 21st Century,” Dr. Pomeranz and Dr. Mendi review the considerations for conducting DCE-MRI studies in oncology trials and for properly planning imaging protocol to address them.
May 01, 2008 - source
R&D Directions - Screen Door is Wide Open
WCC President Rick Taranto, along with executives from Wyeth, Merck, Parexel and Caliper Life Sciences, shares his thoughts on the value of imaging biomarkers to the early stages of the drug discovery process in the “Biomarkers: Expanding Their Discovery” special section in the April 2008 issue of R&D Directions (pg 16-32). In his discussion, Taranto specifically highlights WCC’s use of DCE-MRI biomarkers in cancer trials in collaboration with MGH. (Subscription required)
April 01, 2008 - source
WorldCare Clinical Moves Corporate Headquarters
WorldCare Clinical, LLC (WCC), a leading imaging clinical research organization (CRO), today announced that it has relocated to Boston, Massachusetts to accommodate growing demand for its services. The company’s headquarters, which include a central rea.....
January 28, 2008 - read more
Massachusetts General Hospital Vice Chairman and WorldCare Clinical President to Co-Present at CBI's 4th Annual Medical Imaging for Clinical Trials Conference
WHO: Giles Boland, M.D., vice chairman, Department of Radiology at Massachusetts General Hospital and associate professor of radiology at Harvard Medical School, and Rick Taranto, president of WorldCare Clinical, will present “Independent Radiolo.....
October 26, 2007 - read more
Applied Clinical Trials - Imaging Sites and Clinical Trial Harmony
WCC Director of Clinical Operations Christina Mastandrea reviews the necessary steps for coordinating multisite imaging trials in the the October 2007 issue of Applied Clinical Trials. In her site harmonization overview, Mastandrea emphasizes the importance of standardizing image acquisition protocol, and delineates the most effective ways to minimize the troublesome variances at each stage of a trial.
October 01, 2007 - source
WCC Introduces WorldPro Technology Platform for Maximizing the Efficiency of Clinical Trial Imaging
WorldCare Clinical, LLC (WCC), a leading imaging clinical research organization (CRO), today introduced a sophisticated new software platform for improving workflow efficiency in clinical trial imaging. WCC’s proprietary technology, WorldPRO, streamline.....
September 17, 2007 - read more
GCPj - A Review of Optical Coherence Tomography in Cardiovascular Research
WCC radiologist Dr. Jim Homsy reviews a new medical imaging text focusing on OCT in the September 2007 issue of Good Clinical Practice Journal (pg 40). Providing a thorough content summary and evaluation, Dr. Homsy sheds new light on a hot topic and recommends the work to physicians who regularly deal with atherosclerosis.
September 01, 2007
PharmaVoice - The PharmaVoice 100
ProScan CEO and WCC Chief Medical Officer Dr. Stephen Pomeranz is named one of the 100 Most Inspiring People in the life sciences industry in the special July/August 2007 issue of PharmaVOICE (pg 46-47). Recognized as a “Risk Taker,” Dr. Pomeranz is profiled as “an inspiration to those in the field of medical imaging.”
August 01, 2007 - source
WorldCare Clinical to Exhibit at DIA 43rd Annual Meeting
WHO: WorldCare Clinical (WCC), a leading Imaging CRO for clinical trials, will exhibit in booth 1754 at the Drug Information Association’s (DIA) 43rd Annual Meeting.WHAT: With more than 1,000 speakers from the FDA, EMEA, and other r.....
June 17, 2007 - read more
Specialty Pharma - Imaging CROs & Their Impact on Clinical Trials
WCC President Rick Taranto identifies the critical qualities to consider when choosing a central imaging CRO in Specialty Pharma’s cover story inside Drug Delivery Technology’s June 2007 issue (pg 72-76). In sharing his management expertise and practical industry knowledge, Taranto addresses the importance of imaging CROs to specialty pharmas and the impact they can have on clinical trials.
June 01, 2007
Contract Pharma - Imaging in Clinical Trials
WCC President Rick Taranto provides a thoughtful overview of managing imaging for clinical trials in Contract Pharma’s May 2007 “CRO Industry Update” (pg 44). In his discussion of the administrative concerns for imaging CROs during clinical trials, Taranto reviews the necessary steps for handling image acquisition and organization from multiple sites.
May 01, 2007 - source
WorldCare Clinical Forms Partnership with University of Chicago to Expand Image Reading Services
WorldCare Clinical, LLC (WCC), a leading imaging clinical research organization (CRO), today announced it has entered into a partnership with the University of Chicago Medical Center (UCMC) to augment its medical image analysis and interpretation capabi.....
April 23, 2007 - read more
WorldCare Clinical President to Co-Present with Massachusetts General Hospital Vice Chairman at Oncology Clinical Trials 2007
WHO: Giles Boland, M.D., vice chairman, Department of Radiology at Massachusetts General Hospital and associate professor of radiology at Harvard Medical School, and Rick Taranto, president of WorldCare Clinical, will present “Imaging in Oncology.....
April 10, 2007 - read more
Proscan - Cincinnati's Top Doctors
ProScan CEO and WCC Chief Medical Officer Dr. Stephen Pomeranz is named one of the best doctors in the Greater Cincinnati area by his peers in the April 2007 issue of Cincinnati Magazine, accompanied by 14 of his contemporaries within the radiology specialty.
April 01, 2007 - source
Bio-IT World - WorldCare Clinical in Expansionist Mode
With its acquisition by Cincinnati-based ProScan Imaging in mid-2006, WorldCare Clinical (WCC) gained new radiological expertise in more than 20 subspecialty and “super subspecialty” areas that is available “on a moment’s notice” during clinical trials. The buyout also gave WCC the wherewithal to expand geographically beyond its headquarters near Massachusetts General Hospital (MGH) in Cambridge.
March 23, 2007 - source
R&D Directions
ProScan CEO and WCC Chief Medical Officer Dr. Stephen Pomeranz and ProScan lead technologist Jeff Bryant compare imaging vendors and equipment for clinical trials in the February 2007 issue of R&D Directions (pg 12-14). In their evaluation of the strengths and weaknesses of the MRI, CT and PET product lines of five major industry vendors, Dr. Pomeranz and Bryant provide an interesting and informative look at the technological options for trial sponsors.
February 01, 2007
GCPj - Imaging on Trial: MRI Versus CT
ProScan CEO and WCC Chief Medical Officer Dr. Stephen Pomeranz and WCC President Rick Taranto discuss the pros and cons of the MRI and CT modalities for clinical researchers when developing trials in the January 2007 issue of Good Clinical Practice Journal (pg 22-25). Exploring the differences in scanner technology, the suitability to anatomical region, and the primary safety considerations of each, Dr. Pomeranz and Taranto lend their technical knowledge and hands-on experience to the science of clinical research.
January 01, 2007 - source
PharmaVoice - Clinical Imaging: The Key to Reducing Drug Development Costs
WCC President Rick Taranto makes the case for the value of clinical imaging in PharmaVOICE’s 2007 annual “Year in Preview” issue (pg 36). As a featured thought leader, Taranto explains how the use of imaging biomarkers in pharmaceutical testing can help speed data availability, increase investigative efficiency, and subsequently reduce costs over the course of the drug-development process.
December 01, 2006
ProScan Imaging Acquires Majority Share of WorldCare Clinical
Cincinnati-based ProScan Imaging, LLC, today announced that it has acquired 51 percent ownership of WorldCare Clinical (WCC) from its parent company, WorldCare Limited, a pioneer and leader in the development, commercialization, and distribution of glob.....
June 06, 2006 - read more
WorldCare Clinical Names Scientific Advisory Board Members
WorldCare Clinical, LLC (WCC), a central imaging core lab that specializes in the expert interpretation, measurement, and analysis of medical images as a proven strategy for accelerating clinical trials, today announced the appointment of ten members of.....
June 06, 2006 - read more
More 'News & Events'...